Clinical trials
Aphakia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Withdrawn | 2 |
| Unknown status | 2 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Suspended | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 21 |
| Hoya Surgical Optics, Inc. | 4 |
| RxSight, Inc. | 4 |
| ClarVista Medical | 3 |
| Ophtec USA | 2 |
| PowerVision | 2 |
| Bausch Health Americas, Inc. | 1 |
| Benha University | 1 |
| Cairo University | 1 |
| Changzhou Second People's Hospital affiliated with Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aphakia | 46 |
| Cataract | 33 |
| Presbyopia | 12 |
| Astigmatism | 9 |
| Corneal Endothelial Cell Loss | 1 |
| Ectopia Lentis | 1 |
| Joint Dislocations | 1 |
| Lens Subluxation | 1 |
| Marfan Syndrome | 1 |
| Mydriasis | 1 |
Trials
Showing 76 to 46 of 46. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.